Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 16;25(2):100.
doi: 10.3892/etm.2023.11799. eCollection 2023 Feb.

De novo 3q13.13q21.2 interstitial deletion and paternal 12p13.3 microdeletion in a fetus with dysplasia of the corpus callosum and ventriculomegaly: A case report

Affiliations
Case Reports

De novo 3q13.13q21.2 interstitial deletion and paternal 12p13.3 microdeletion in a fetus with dysplasia of the corpus callosum and ventriculomegaly: A case report

Francesco Libotte et al. Exp Ther Med. .

Abstract

Chromosome 3q syndrome is a well-known genetic condition caused by interstitial deletion in the long arm of chromosome 3. The phenotype of this syndrome is variable and the great variability in the extent of these deletions leads to a wide spectrum of clinical manifestations. Terminal 12p deletion represents one of the rarest subtelomeric imbalances; patients with distal monosomy 12p present different phenotypes ranging from muscular hypotonia to autism spectrum disorders. The present study reported a prenatal diagnosis of a male fetus presenting ultrasound evidence of corpus callosum dysplasia and ventriculomegaly showing a 3q13q21.2 deletion and a 12p13.33 microdeletion paternally inherited. Among several features previously attributed to the terminal deletion of 3q, corpus callosum dysplasia and ventriculomegaly have rarely been reported together. As the 12p13.33 microdeletion in the father was associated only with muscular hypotonia and joint laxity, the involvement of terminal 12p deletions in the clinical features of the fetus was not possible to verify during the prenatal period. The present case report may provide a reference for prenatal diagnosis and genetic counseling in patients who present 3q13q21.2 deletions and 12p13.33 microdeletion.

Keywords: 12p13.3 microdeletion; 3q-syndrome; 3q13.13q21.2 deletion; aCGH; corpus callosum dysplasia; cytogenetic; karyotype; muscular hypotonia; prenatal diagnosis; ventriculomegaly.

PubMed Disclaimer

Conflict of interest statement

All authors are full-time employees of Artemisia SPA. ALTAMEDICA is a branch of Artemisia SPA involved in Human Genetics and Fetal-Maternal Medical Sciences.

Figures

Figure 1
Figure 1
Ultrasound evidence of clinical features of fetus. (A) Red arrows show the corpus callosum dysplasia, which presents as thin. (B) Red arrows show the corpus callosum dysplasia, which is not clearly visible. (C) Axial view of fetal cerebral ventriculomegaly (yellow arrow). (D) Sagittal view of the fetal face shows a flat forehead and facial profile.
Figure 2
Figure 2
G-banded karyotype of fetus and relative ideogram showing the region of chromosome 3 harboring the 3q deletion.
Figure 3
Figure 3
The scatter plot of the array comparative genomic hybridization of the fetus. (A) The deletion at the region 3q13.13q21.2 is estimated to be 12.87 Mb (from 111162064 to 124034052 kb) harboring 81 OMIM genes. (B) The deletion at the region 12p13.33 is estimated to be 1.23 Mb (from 100698 to 1327097 kb) harboring 16 OMIM genes. OMIM, Online Mendelian Inheritance in Man.
Figure 4
Figure 4
Coding genes and graphical representation of 12 chromosome region (12p13.33) involved in microdeletion. The deletion at 12p13.33 detected in our patient is represented by a red box on chromosome. 12p13.33 microdeletion in our patient overlapping pathogenic/likely pathogenic deletions (red bars) in other cases present in the Decipher database (https://decipher.sanger.ac.uk/) presenting (A) hypotonia or (B) joint laxity.

Similar articles

Cited by

References

    1. Ramieri V, Tarani L, Costantino F, Basile E, Liberati N, Rinna C, Cascone P, Colloridi F. Microdeletion 3q syndrome. J Craniofac Surg. 2011;22:2124–2128. doi: 10.1097/SCS.0b013e3182323cdf. - DOI - PubMed
    1. Molin AM, Andrieux J, Koolen DA, Malan V, Carella M, Colleaux L, Cormier-Daire V, David A, de Leeuw N, Delobel B, et al. A novel microdeletion syndrome at 3q13.31 characterised by developmental delay, postnatal overgrowth, hypoplastic male genitals, and characteristic facial features. J Med Genet. 2012;49:104–109. doi: 10.1136/jmedgenet-2011-100534. - DOI - PMC - PubMed
    1. Tanaka-Arakawa MM, Matsui M, Tanaka C, Uematsu A, Uda S, Miura K, Sakai T, Noguchi K. Developmental changes in the corpus callosum from infancy to early adulthood: A structural magnetic resonance imaging study. PLoS One. 2015;10(e0118760) doi: 10.1371/journal.pone.0118760. - DOI - PMC - PubMed
    1. Hofman J, Hutny M, Sztuba K, Paprocka J. Corpus callosum agenesis: An insight into the etiology and spectrum of symptoms. Brain Sci. 2020;10(625) doi: 10.3390/brainsci10090625. - DOI - PMC - PubMed
    1. Hanna RM, Marsh SE, Swistun D, Al-Gazali L, Zaki MS, Abdel-Salam GM, Al-Tawari A, Bastaki L, Kayserili H, Rajab A, et al. Distinguishing 3 classes of corpus callosal abnormalities in consanguineous families. Neurology. 2011;76:373–382. doi: 10.1212/WNL.0b013e318208f492. - DOI - PMC - PubMed

Publication types